Aktis Oncology (AKTS) Income Statement

Aktis Oncology reported revenue of $6.50M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 336.9% from $1.49M a year earlier. Aktis Oncology posted a net loss of $63.73M, compared with a net loss of $43.98M a year earlier. Gross margin was 100.0% and operating margin -1149.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $3.38M, up 111.4% from the same quarter a year earlier.

Aktis Oncology Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Aktis Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	6.50	1.49	0.00	0.00
Cost of Revenue	67.45	0.00	0.00	0.00
Gross Profit	6.50	1.49	0.00	0.00
Operating Expenses
Research & Development	67.45	40.95	25.92	14.30
Selling, General & Administrative	13.73	11.31	7.68	5.46
Operating Expenses	81.18	53.54	34.79	19.76
Operating Income	-74.68	-52.05	-34.79	-19.76
Other Income/Expense
Interest Income	11.01	8.10	5.38	1.65
Interest Expense	0.00	0.00	0.00	0.00
Other Income/Expense	10.95	8.07	6.15	1.84
Income
Income Before Tax	-63.73	-43.98	-28.64	-17.93
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-63.73	-43.98	-28.64	-17.93
Net Income - Continuous Operations	-63.73	-43.98	-28.64	-17.93
Net Income - Discontinued Operations	-	-	-	-
EBITDA	-72.36	-42.41	-27.45	-19.32
EBIT	-74.68	-52.05	-34.79	-19.76
Depreciation & Amortization	2.33	1.58	1.20	0.45
Earnings Per Share
Basic EPS	-78.00	-1.00	-1.00	-35.00
Diluted EPS	-78.00	-1.00	-1.00	-35.00
Basic Shares Outstanding	0.81	34.86	34.86	0.52
Diluted Shares Outstanding	0.81	34.86	34.86	0.52

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Aktis Oncology Financial Statements

What was Aktis Oncology's revenue in fiscal 2025?

Aktis Oncology reported revenue of $6.50M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 336.9% from $1.49M a year earlier.

Is Aktis Oncology profitable?

No. Aktis Oncology reported a net loss of $63.73M in fiscal 2025. In fiscal 2024 it lost $43.98M.

What is Aktis Oncology's operating margin?

Aktis Oncology's operating income was −$74.68M on revenue of $6.50M in fiscal 2025, an operating margin of -1149.5%, compared with -3500.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition